4.8 Article

SARS-CoV-2 Point-of-Care (POC) Diagnosis Based on Commercial Pregnancy Test Strips and a Palm-Size Microfluidic Device

Journal

ANALYTICAL CHEMISTRY
Volume 93, Issue 35, Pages 11956-11964

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.1c01829

Keywords

-

Funding

  1. National Natural Science Foundation of China [21874129, 22004118, 22174137]
  2. National Key R&D Program of China [2019YFC1905400]
  3. International Technological Cooperation Project of Jilin Scientific and Technological Development Program [20200801044GH]
  4. New coronavirus (COVID-19) emergency project of Jilin Province [20200901022SF]

Ask authors/readers for more resources

A portable and accurate nucleic acid detection system was developed to address the urgent need for on-site virus screening and infection control. It utilizes ultrasensitive isothermal amplification to achieve rapid and sensitive detection of SARS-CoV-2 RNA, providing a cost-effective solution for emergency detection of the virus.
Coronavirus diseases such as the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), pose serious threats. Portable and accurate nucleic acid detection is still an urgent need to achieve on-site virus screening and timely infection control. Herein, we have developed an on-site, semiautomatic detection system, aiming at simultaneously overcoming the shortcomings suffered by various commercially available assays, such as low accuracy, poor portability, instrument dependency, and labor intensity. Ultrasensitive isothermal amplification [i.e., reverse transcription loop-mediated isothermal amplification (RT-LAMP)] was applied to generate intensified SARS-CoV-2 RNA signals, which were then transduced to portable commercial pregnancy test strips (PTSs) via ultraspecific human chorionic gonadotropin (hCG)-conjugated toehold-mediated strand exchange (TMSE) probes (hCG-P). The entire detection was integrated into a four-channel, palm- size microfluidic device, named the microfluidic point-of-care (POC) diagnosis system based on the PTS (MPSP) detection system. It provides rapid, cost-effective, and sensitive detection, of which the lowest concentration of detection was 0.5 copy/mu L of SARSCoV-2 RNA, regardless of the presence of other similar viruses, even highly similar severe acute respiratory syndrome coronavirus (SARS-CoV). The successful detection of the authentic samples from different resources evaluated the practical application. The commercial PTS provides a colorimetric visible signal, which is instrument- and optimization-free. Therefore, this MPSP system can be immediately used for SARS-CoV-2 emergency detection, and it is worthy of further optimization to achieve full automation and detection for other infectious diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available